Bulletin
Investor Alert

New York Markets After Hours

Moleculin Biotech Inc.

NAS: MBRX

GO
/marketstate/country/us

After Hours

/zigman2/quotes/209653941/composite

$

0.79

Change

-0.01 -1.74%

Volume

Volume 6,126

Sep 29, 2020, 5:35 p.m.

Real time quotes

/zigman2/quotes/209653941/composite

Today's close

$ 0.80

$ 0.80

Change

+0.0002 +0.03%

Day low

Day high

$0.78

$0.90

Open
Open: 0.86

52 week low

52 week high

$0.32

$1.97

Open

Market cap

$49.35M

Average volume

1.92M

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-0.37

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/nonmarketwatch/company/us/mbrx

Other News on MBRX

  1. Moleculin to conduct in vitro for WP1096 in COVID-19, shares up 2%

    10:10 a.m. Today

    - Seeking Alpha

  2. Moleculin Biotech discovers additional anti-SARS-CoV-2 molecule

    9:59 a.m. Today

    - Seeking Alpha

  3. Moleculin to conduct in vivo for WP1122 in COVID-19

    8:00 a.m. Sept. 14, 2020

    - Seeking Alpha

  4. Moleculin Biotech (MBRX) Investor Presentation - Slideshow

    7:03 p.m. Sept. 2, 2020

    - Seeking Alpha

  5. 10-Q: MOLECULIN BIOTECH, INC.

    7:32 a.m. Aug. 12, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  6. OPK, NBEV among premarket gainers

    8:23 a.m. July 21, 2020

    - Seeking Alpha

  7. Moleculin inks production deal for COVID-19 candidate WP1122

    8:06 a.m. July 15, 2020

    - Seeking Alpha

  8. Moleculin Bio updates on annamycin development

    8:01 a.m. July 2, 2020

    - Seeking Alpha

  9. Moleculin Bio confirms antiviral potential of WP1122

    8:37 a.m. June 16, 2020

    - Seeking Alpha

  10. M, OPK among premarket gainers

    9:16 a.m. June 9, 2020

    - Seeking Alpha

  11. Agenus' (AGEN) IND for iNKT Therapy Gets FDA Acceptance

    11:56 a.m. May 14, 2020

    - Zacks.com

  12. Loading more headlines...
/news/pressrelease/company/us/mbrx

Press Releases on MBRX

  1. Moleculin Announces COVID-19 In Vivo Testing Contracted for WP1122

    7:30 a.m. Sept. 14, 2020

    - PR Newswire - PRF

  2. Moleculin to Present at Upcoming Healthcare Investor Conferences

    7:30 a.m. Sept. 10, 2020

    - PR Newswire - PRF

  3. LD Micro - 360 Companies - Set to Present this Week

    5:00 p.m. Aug. 31, 2020

    - ACCESSWIRE

  4. Moleculin to Present at LD Micro 500 Virtual Investor Conference

    7:30 a.m. Aug. 27, 2020

    - PR Newswire - PRF

  5. Moleculin Provides Update on Annamycin Clinical Development

    7:30 a.m. July 2, 2020

    - PR Newswire - PRF

  6. Moleculin to Present at the Life Sciences Investor Forum

    7:30 a.m. June 23, 2020

    - PR Newswire - PRF

  7. Moleculin Announces Confirmatory In Vitro Analysis of WP1122

    7:30 a.m. June 16, 2020

    - PR Newswire - PRF

  8. Loading more headlines...

Rates »

Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.